Chemical Structure (Image 1)
Ethacrynate Sodium Injection, Powder, For Solution
Product Images NDC 42023-157
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ethacrynate Sodium (NDC 42023-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Image 2)
Carton 3003371a (Image 3)
Ethacrynate Sodium is a medication given through intravenous injection to patients to help relieve fluid retention in the body. Each vial contains 50mg of the active ingredient known as ethacrynic acid, and 62.5mg of mannitol. Ethacrynate Sodium is FDA approved and requires a prescription. It is typically administered in a slow injection with 5% Dextrose Injection or Sodium Chloride Injection as soon as it is reconstituted, and must be discarded 24 hours after preparation. The vial stopper is not made with natural rubber latex, and the medication should be stored in a tightly closed container within the temperature range of 20° to 25°C (68° to 77°F). The recommended adult dosage is between 0.5 to 1.0 mg of ethacrynic acid per kg of body weight. The package includes one 50 mg/vial single dose vial. More information can be found in the full prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
